| 摘要 |
The present invention relates to a melanin concentrating hormone antagonist compound of formula (I); wherein Ar<SUP>1</SUP>, L<SUB>1</SUB>, R<SUP>1</SUP>, q, X, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4</SUP>, and R<SUP>5</SUP> are as defined, or a pharmaceutically acceptable salt, solvate, or enantiomer thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases. |
| 申请人 |
ELI LILLY AND COMPANY;BECK, JAMES, PETER;WAKEFIELD, BRIAN, DAVID;CORDIER, FREDERIC, LAURENT;DOMINGUEZ-MANZANARES, ESTEBAN;GARDINIER, KEVIN, MATTHEW;GREENEN, PETER, MICHAEL;SAVIN, KENNETH, ALLEN |
发明人 |
BECK, JAMES, PETER;WAKEFIELD, BRIAN, DAVID;CORDIER, FREDERIC, LAURENT;DOMINGUEZ-MANZANARES, ESTEBAN;GARDINIER, KEVIN, MATTHEW;GREENEN, PETER, MICHAEL;SAVIN, KENNETH, ALLEN |
